These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 2611137)
1. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia. Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137 [TBL] [Abstract][Full Text] [Related]
2. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation. Fournier DJ; Kabral A; Castaldi PA; Berndt MC Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684 [TBL] [Abstract][Full Text] [Related]
3. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957 [TBL] [Abstract][Full Text] [Related]
4. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation. Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006 [TBL] [Abstract][Full Text] [Related]
5. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa. Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274 [TBL] [Abstract][Full Text] [Related]
6. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841 [TBL] [Abstract][Full Text] [Related]
7. Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight. Jung SM; Yoshida N; Aoki N; Tanoue K; Yamazaki H; Moroi M Blood; 1988 Apr; 71(4):915-22. PubMed ID: 3355897 [TBL] [Abstract][Full Text] [Related]
8. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia. Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422 [TBL] [Abstract][Full Text] [Related]
9. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets. Khaspekova SG; Vlasik TN; Byzova TV; Vinogradov DV; Berndt MC; Mazurov AV Br J Haematol; 1993 Oct; 85(2):332-40. PubMed ID: 7506568 [TBL] [Abstract][Full Text] [Related]
10. A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. Tanoue K; Hasegawa S; Yamaguchi A; Yamamoto N; Yamazaki H Thromb Res; 1987 Aug; 47(3):323-33. PubMed ID: 3629560 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay. Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944 [TBL] [Abstract][Full Text] [Related]
12. A variant of Glanzmann's thrombasthenia which fails to express a GPIIb-IIIa related epitope that is recognized by a specific monoclonal antibody (C17). Escolar G; Diaz-Ricart M; Garrido M; Reverter JC; Villamor N; Sanz C; Maragall S; Castillo R; Ordinas A; Nurden AT Br J Haematol; 1992 Aug; 81(4):545-51. PubMed ID: 1382548 [TBL] [Abstract][Full Text] [Related]
13. Diversity of glycoprotein deficiencies in Glanzmann's thrombasthenia. Meyer M; Herrmann FH Thromb Haemost; 1985 Oct; 54(3):626-9. PubMed ID: 2935964 [TBL] [Abstract][Full Text] [Related]
14. [Glanzmann's thrombasthenia: a rare example of an integrin deficit]. Perutelli P; Mori PG Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042 [TBL] [Abstract][Full Text] [Related]
15. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911 [TBL] [Abstract][Full Text] [Related]
16. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Boukerche H; McGregor JL Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471 [TBL] [Abstract][Full Text] [Related]
17. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies. Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579 [TBL] [Abstract][Full Text] [Related]